NDC product
Naloxone Hydrochloride Injection, USP, Auto-Injector
NDC 60842-002 · Kaleo, Inc.
Key facts
| Product NDC | 60842-002 |
|---|---|
| Proprietary name | Naloxone Hydrochloride Injection, USP, Auto-Injector |
| Nonproprietary name | Naloxone Hydrochloride |
| Substances | NALOXONE HYDROCHLORIDE |
| Dosage form | INJECTION, SOLUTION |
| Route | INTRAMUSCULAR, SUBCUTANEOUS |
| Labeler | Kaleo, Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Application number | NDA215457 |
| Pharmacologic classes | Opioid Antagonist [EPC], Opioid Antagonists [MoA] |
| Marketing start | Feb 28, 2022 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: